Net loss of Vaishali Pharma reported to Rs 4.68 crore in the quarter ended March 2024 as against net profit of Rs 0.44 crore during the previous quarter ended March 2023. Sales rose 23.48% to Rs 32.40 crore in the quarter ended March 2024 as against Rs 26.24 crore during the previous quarter ended March 2023.For the full year,net profit declined 89.09% to Rs 0.72 crore in the year ended March 2024 as against Rs 6.60 crore during the previous year ended March 2023. Sales rose 23.86% to Rs 86.28 crore in the year ended March 2024 as against Rs 69.66 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales32.4026.24 23 86.2869.66 24 OPM %-20.932.97 -1.3313.09 - PBDT-6.270.77 PL 1.449.34 -85 PBT-6.410.62 PL 0.938.84 -89 NP-4.680.44 PL 0.726.60 -89 Powered by Capital Market - Live News

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 17 May 2024Powered by Capital Market - Live News

Net profit of Vaishali Pharma declined 20.68% to Rs 2.11 crore in the quarter ended December 2023 as against Rs 2.66 crore during the previous quarter ended December 2022. Sales rose 38.88% to Rs 27.90 crore in the quarter ended December 2023 as against Rs 20.09 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales27.9020.09 39 OPM %10.5417.72 - PBDT2.983.67 -19 PBT2.863.55 -19 NP2.112.66 -21 Powered by Capital Market - Live News

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 2 February 2024.Powered by Capital Market - Live News